PL2307380T3 - Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego - Google Patents
Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowegoInfo
- Publication number
- PL2307380T3 PL2307380T3 PL09772373T PL09772373T PL2307380T3 PL 2307380 T3 PL2307380 T3 PL 2307380T3 PL 09772373 T PL09772373 T PL 09772373T PL 09772373 T PL09772373 T PL 09772373T PL 2307380 T3 PL2307380 T3 PL 2307380T3
- Authority
- PL
- Poland
- Prior art keywords
- nitroxyalkylnicotinamides
- treatment
- cardiovascular diseases
- cardiovascular
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL38556108 | 2008-07-01 | ||
PCT/EP2009/058017 WO2010000673A1 (en) | 2008-07-01 | 2009-06-26 | N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases |
EP09772373A EP2307380B1 (en) | 2008-07-01 | 2009-06-26 | N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2307380T3 true PL2307380T3 (pl) | 2013-01-31 |
Family
ID=41058686
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL09772373T PL2307380T3 (pl) | 2008-07-01 | 2009-06-26 | Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego |
Country Status (5)
Country | Link |
---|---|
US (1) | US20110082177A1 (pl) |
EP (1) | EP2307380B1 (pl) |
CA (1) | CA2764739A1 (pl) |
PL (1) | PL2307380T3 (pl) |
WO (1) | WO2010000673A1 (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL238932B1 (pl) * | 2017-12-31 | 2021-10-18 | Univ Jagiellonski | Pochodne soli pirydyniowych oraz ich zastosowanie |
CA3123531A1 (en) * | 2019-01-02 | 2020-07-09 | Celagenex Research (India) Pvt. Ltd. | Synergistic combinations of nicotinamide and nitrate enriched amaranthus extract for use in treating vascular endothelial disorders |
CN116253679B (zh) * | 2023-01-12 | 2023-09-15 | 北京沃邦医药科技有限公司 | 一种尼可地尔精制母液回收品的精制方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK145608C (da) * | 1976-04-02 | 1983-07-11 | Chugai Pharmaceutical Co Ltd | Analogifremgangsmaade til fremstilling af salpetersyreesteren af n-(2-hydroxyethyl)nicotinamid |
PL364348A1 (pl) * | 2004-01-12 | 2005-07-25 | PHARMENA Sp.z o.o. | Zastosowanie czwartorzędowych soli pirydyniowych jako środka naczynioprotekcyjnego |
-
2009
- 2009-06-26 US US12/997,500 patent/US20110082177A1/en not_active Abandoned
- 2009-06-26 EP EP09772373A patent/EP2307380B1/en not_active Not-in-force
- 2009-06-26 PL PL09772373T patent/PL2307380T3/pl unknown
- 2009-06-26 WO PCT/EP2009/058017 patent/WO2010000673A1/en active Application Filing
- 2009-06-26 CA CA2764739A patent/CA2764739A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20110082177A1 (en) | 2011-04-07 |
WO2010000673A1 (en) | 2010-01-07 |
CA2764739A1 (en) | 2010-01-07 |
EP2307380A1 (en) | 2011-04-13 |
EP2307380B1 (en) | 2012-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272817A (en) | New preparations and methods for the treatment of vaccine-related diseases | |
EP2118074A4 (en) | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIAC DISEASES | |
ZA201001304B (en) | Compositions for the treatment of neoplastic diseases | |
PL2546253T3 (pl) | Podstawione dihydropirazolony do leczenia schorzeń sercowo-naczyniowych i hematologicznych | |
IL216967B (en) | The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases | |
IL211313A0 (en) | Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies | |
EP2320939A4 (en) | TISSUE CALLICLE FOR THE TREATMENT OF PARKINSON DISEASE | |
GB0909297D0 (en) | Composition for the treatment of skin conditions | |
SI2234631T1 (sl) | Spojine in postopki za zdravljenje ĺ˝ilne bolezni | |
IL213703A (en) | Compounds for the treatment of pain and other diseases | |
IL207247A0 (en) | Use of ranolazine for the treatment of cardiovascular disease | |
PL2307380T3 (pl) | Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego | |
PL2323625T3 (pl) | Nowa kompozycja do leczenia pigmentacji wybroczynowych | |
HK1185345A1 (zh) | 用於預防和治療心血管疾病的化合物 | |
EP2240024A4 (en) | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | |
GB0814043D0 (en) | The treatment of skin disorders | |
GB0602857D0 (en) | The treatment of sialorrhoea | |
GB0809319D0 (en) | The treatment of puritus | |
GB0716840D0 (en) | Treatment of cardiovascular disease | |
GB0602855D0 (en) | The Treatment Of Sialorrhoea | |
GB0602858D0 (en) | The treatment of sialorrhoea | |
IL208127A0 (en) | Ptph1 inhibitors for the treatment of alzheimer's disease | |
GB0801511D0 (en) | The treatment of ophthalmic diseases | |
GB0811555D0 (en) | Treatment of Alzheimer's disease | |
GB0600237D0 (en) | The treatment of pre-term labour |